Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results